Problems of solute removal in continuous renal replacement therapies

Complications of Dialysis

Volumn , Issue , 2000, Pages 251-268

  Clark, William R ^a,b   Kraus, Michael A ^b   Mueller, Bruce A ^c  

^a Renal Division   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84955655336     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Douma C, Redekop W, Van Der Meulen J, Van Olden R, Haeck J, Struijk D, Krediet R. Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol 1997; 8: 111-117.
2. Lysaght M. Evolution of hemodialysis membranes. Contrib Nephrol 1995; 113: 1-10.
3. Colton C, Lowrie E. Hemodialysis: physical principles and technical considerations. In: Brenner B, Rector F, eds. The Kidney. 2d ed. Philadelphia: W.B. Saunders Co., 1981: 2425-2489.
4. Colton C. Analysis of membrane processes for blood purification. Blood Purif 1987; 5: 202-251.
5. Sargent J, Gotch F. Principles and biophysics of dialysis. In: Maher J, ed. Replacement of Renal Function by Dialysis. 3rd ed. Dordrecht: Kluwer Academic Publishers, 1989: 89-91.
6. Colton CK, Lysaght M. Membranes for hemodialysis. In: Jacobs C, ed. Replacement of Renal Function by Dialysis. 4th ed. Dordrecht: Kluwer Academic Publishers, 1995: 107-108.
7. Henderson LW. Biophysics of ultrafiltration and hemofiltration. In: Jacobs C, ed. Replacement of Renal Function by Dialysis. 4th ed. Dordrecht: Kluwer Academic Publishers, 1995: 114-118.
8. Ofsthun NJ, Zydney AL. Importance of convection in artificial kidney treatment. Contrib Nephrol 1994; 108: 53-70.
9. Scott MK, Mueller BA, Clark WR. Effect of membrane type on the performance of bleach-reprocessed highflux dialyzers (abstr). J Am Soc Nephrol 1997; 8: 172A.
10. Naitoh A, Tatsuguchi T, Okada M, Ohmura T, Sakai K. Removal of beta-2-microglobulin by diffusion alone is feasible using highly permeable dialysis membranes. Trans Am Soc Artif Intern Organs 1988; 34: 630-634.
11. 2-microglobulin removal between cellulosic and synthetic polymer membrane dialyzers. TransAm Soc Artif Intern Organs 1990; 36: M643-M646.
12. Rockel A, Hertel J, Fiegel P, Abdelhamid S, Panitz N, Walb D. Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int 1986; 30: 429-432.
13. Kim S. Characteristics of protein removal in hemodiafiltration. Contr Nephrol 1994; 108: 23-37.
14. Henderson LW. Pre vs post dilution hemofiltration. Clin Nephrol 1979; 11: 120-124.
15. Grootendorst AF, Van Bommel EFH, Van Der Hoven B. High-volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. Intensive Care Med 1992; 18: 235-240.
16. Grootendorst AF, Van Bommel EFH, Van Leengoed LAMG, Van Der Hoven B. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993; 8: 161-169.
17. Werynski A, Waniewski J. Theoretical description of mass transport in medical membrane devices. Artif Organs 1995; 19: 420-427.
18. Jaffrin M. Convective mass transfer in hemodialysis. Artif Organs 1995; 19: 1162-1171.
19. Geronemus R, Schneider N. Continuous arteriovenous hemodialysis: a new modality for treatment of acute renal failure. Trans Am Soc Artif Intern Organs 1984; 30: 610-612.
20. Sigler MH, Teehan BP. Solute transport in continuous hemodialysis: a new treatment for renal failure. Kidney Int 1987; 32: 562-571.
21. Relton S, Greenberg A, Palevsky P. Dialysate and blood flow dependence of diffusive solute clearance during CVVHD. ASAIO J 1992; 38: 691-696.
22. Ifedoria O, Teehan B, Sigler M. Solute clearance in continuous venovenous hemodialysis. ASAIO J 1992; 38: 697-701.
23. Mehta RL. Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin Nephrol 1994; 14: 64-82.
24. Scott MK, Mueller BA, Clark WR. Vancomycin mass transfer characteristics of high flux cellulosic dialyzers. Nephrol Dial Transplant 1997; 12: 2647-2653.
25. Jeffrey RF, Khan AA, Prabhu P, Todd N, Goutcher E, Will EJ, Davison AM. A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system. Artif Organs 1994; 18: 425-428.
26. 2-microglobulin: equilibrium and kinetic characterization. Kidney Int 1994; 46: 1140-1146.
27. Pascual M, Schifferli JA. Adsorption of complement factor D by polyacrylonitrile dialysis membranes. Kidney Int 1993; 43: 903-911.
28. Goldfarb S, Golper TA. Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 1994; 5: 228-232.
29. Bellomo R, Tipping P, Boyce N. Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. Trans Am Soc Artif Intern Organs 1991; 37: M322-M323.
30. Riera JA, Vela JL, Quintana MJ, Lopez E, de Solo B, Checa A. Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis 1997; 30: 483-488.
31. Scott MK, Mueller BA, Clark WR. Dialyzer-dependent changes in solute and water permeability with bleach reprocessing. Am J Kidney Dis. In press.
32. Clark WR, Macias WL, Molitoris BA, Wang NHL. Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 1995; 48: 481-488.
33. Kaplan AA, Halley SE, Lapkin RA, Graeber CW. Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995; 47: 573-578.
34. Macias WL, Mueller BA, Scarim SK, Robinson M, Rudy D. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 1991; 18: 451-458.
35. Canaud B, Garred L, Christol J, Anbas S, Beraud J, Mion C. Pump-assisted continuous venovenous hemofiltration for treating acute uremia. Kidney Int 1988; 33: S154-S156.
36. Golper T, Erbeck K, Roberts P, Price J. Small solute sieving coefficients using hemodialyzers as filters in continuous venovenous hemofiltration (abstr). J Am Soc Nephrol 1992; 3: 367.
37. Schaeffer J, Olbricht CJ, Koch KM. Long-term performance of hemofilters in continuous hemofiltration. Nephron 1996; 72: 155-158.
38. Ofsthun NJ, Colton CK, Lysaght MJ. Determinants of fluid and solute removal rates during hemofiltration. In: Henderson L, Quellhorst E, Baldamus C, Lysaght M, eds. Hemofiltration. Berlin: Springer-Verlag, 1986: 17-39.
39. Mokrzycki M, Kaplan AA. Protein losses in continuous renal replacement therapies. J Am Soc Nephrol 1996; 7: 2259-2263.
40. Clark WR, Alaka KJ, Mueller BA, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994; 4: 1413-1420.
41. Chima CS, Meyer L, Hummell AC, Bosworth C, Heyka R, Paganini E, Werynski A. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. JASN 1993; 3: 1516-1521.
42. Feinstein EI, Blumenkrantz MJ, Healy M, Koffler A, Silberman H, Massry S, Kopple J. Clinical and metabolic responses to parenteral nutrition in acute renal failure. Medicine 1981; 60: 124-137.
43. Feinstein EI, Kopple JD, Silberman H, Massry SG. Total parenteral nutrition with high or low nitrogen intakes in patients with acute renal failure. Kidney Int 1983; 26: S319-S323.
44. Ikizler TA, Greene JH, Wingard RL, Hakim RM. Nitrogen balance in acute renal failure (ARF) patients (abstr). JASN 1995; 6: 466.
45. Gotch F. Kinetic modeling in hemodialysis. In: Nissenson A, Fine R, Gentile D, eds. Clinical Dialysis. 2nd ed. Norwalk: Appleton and Lange, 1990: 118-146.
46. Watson P, Watson I, Batt R. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39.
47. Hume R, Weyers E: Relationship between total body water and surface area in normal and obese subjects. J Clin Pathol 1974; 24: 234-238.
48. Malina R. Quantification of fat, muscle, and bone in man. Clin Orthop Relat Res 1969; 65: 9-38.
49. Clark WR, Alaka KJ, Mueller BA, Macias WL. Comparison of metabolic control by intermittent versus continuous renal replacement therapy in patients with acute renal failure (abstr). Trans Am Soc Artif Intern Organs 1993; 39: 95.
50. Clark WR, Murphy MH, Alaka K, Mueller BA, Pastan SO, Macias WL. Urea kinetics in continuous hemofiltration. ASAIO J 1992; 38: M664-M667.
51. Evanson J, Hakim R, Wingard R, Knights S, Schulman G, Ikizler T, Himmelfarb J. Assessment of dialysis dose in acute renal failure patients (abstr). J Am Soc Nephrol 1996; 7: 1512.
52. Clark WR, Mueller BA, Kraus MA, Macias WL. Solute control by extracorporeal therapies in acute renal failure. Am J Kidney Dis 1996; 28(suppl 3): S21-S27.
53. Paganini EP, Tapolyai M, Goormastic M, Halstenberg W, Kozlowski L, Leblanc M, Lee JC, Moreno L, Sakai K. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 1996; 28(suppl 3): S81-S89.
54. Wehle B, Asaba H, Castenfors J. Hemodynamic changes during sequential ultrafiltration and dialysis. Kidney Int 1979; 15: 411-418.
55. Sherman R. The measurement of dialysis access recirculation. Am J Kidney Dis 1993; 22: 616-621.
56. Windus D. Permanent vascular access: A nephrologist’s view. Am J Kidney Dis 1993; 21: 457-471.
57. Twardowski Z, Van Stone J, Jones M, Klusmeyer M, Haynie J. Blood recirculation in intravenous catheters for hemodialysis. J Am Soc Nephrol 1993; 3: 1978-1981.
58. Kelber J, Delmez J, Windus D. Factors affecting delivery of high-efficiency dialysis using temporary vascular access. Am J Kidney Dis 1993; 22: 24-29.
59. Leblanc M, Fedak S, Mokris G, Paganini E. Blood recirculation in central temporary catheters for acute hemodialysis. Clin Nephrol 1996; 45: 315-319.
60. Van Stone J: Hemodialysis apparatus. In: Daugirdas J, Ing T, eds. Handbook of Dialysis. 2d ed. Boston: Little, Brown and Company, 1994: 32-38.
61. Clark WR, Rocco MV, Collins AJ. Quantification of hemodialysis: analysis of methods and the relevance to patient outcome. Blood Purif 1997; 15: 92-111.
62. NKF-DOQI Hemodialysis Adequacy Work Group. Clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 1997; 30(suppl 2): S15-S66.
63. Clark WR, Mueller BA, Kraus MA, Macias WL. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 1997; 8: 804-812.
64. Clark WR, Ronco C. Renal replacement therapy quantification in acute renal failure: solute removal mechanisms and dose quantification. Kidney Int 1998; 53(suppl 66): S133-S137.
65. Kjellstrand C, Jacobson S, Lins L. Acute renal failure. In: Maher J, ed. Replacement of Renal Function by Dialysis. 3rd ed. Dordrecht: Kluwer Academic Publishers, 1989: 616-649.
66. Gornick C, Kjellstrand C. Acute renal failure complicating aortic aneurysm surgery. Nephron 1983; 35: 145-157.
67. Matas M, Payne W, Simmons R, Buselmeier T, Kjellstrand C. Acute renal failure following blunt civilian trauma. Ann Surg 1977; 185: 301-306.
68. Kleinknecht D, Jungers P, Chanard J, Barbanel C, Ganeval D. Uremic and non-uremic complications in acute renal failure: evaluation of early and frequent dialysis on prognosis. Kidney Int 1972; 1: 190-196.
69. Gillum DM, Dixon BS, Yanover MJ, Kelleher S, Shapiro M, Benedetti R, Dillingham M, Paller M, Goldberg J, Tomford R, Gordon J, Conger JD. The role of intensive dialysis in acute renal failure. Clin Nephrol 1986; 25: 249-255.
70. Clark WR, Mueller BA, Kraus MA, Macias WL. Quantification of creatinine kinetic parameters in patients with acute renal failure. Kidney Int 1998; 54: 554-560.
71. Tapolyai M, Fedak S, Chaff C, Paganini E. Delivered dialysis dose may influence ARF outcome in ICU patients (abstr). JASN 1994; 5: 530.
72. Paganini EP, Halstenberg W, Goormastic M. Risk modeling in acute renal failure requiring dialysis: the introduction of a new model. Clin Nephrol 1996; 44: 206-211.
73. Schiffl H, Lang S, Konig A, Held E. Dose of intermittent hemodialysis and outcome of acute renal failure: a prospective randomized study (abstr). J Am Soc Nephrol 1997; 8: 290A.
74. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
75. Lo AJ, Depner TA, Chin ES, Craig MA. Urea disequilibrium contributes to underdialysis in the intensive care unit (abstr). J Am Soc Nephrol 1997; 8: 287A.
76. Storck M, Hartl W, Zimmerer E, Inthorn D. Comparison of pump-driven and spontaneous hemofiltration in postoperative acute renal failure. Lancet 1991; 337: 452-455.
77. Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch J. Continuous arteriovenous hemofiltration in the critically ill patient. Ann Intern Med 1983; 99: 455-460.
78. Kaplan A, Longnecker R, Folkert V. Suction-assisted continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 1983; 29: 408-413.
79. Locatelli F, Pontoreiero G, DiFilippo S. Electrolyte disorders and substitution fluid in continuous renal replacement therapy. Kidney Int 1998; 53(suppl 66): S151-S155.
80. Ikizler TA, Himmelfarb J. Nutrition in acute renal failure patients. Adv Renal Replace Ther 1997; 4(suppl 1): 54-63.
81. Clark WR, Leypoldt JK, Henderson LW, Scott MK, Mueller BA, Vonesh EF. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999; 10: 601-610.
82. Cottrell A, Mehta RL. Phosphate kinetics in continuous renal replacement therapy (abstr). J Am Soc Nephrol 1992; 3: 360.
83. Hynote E, McCamish M, Depner T, Davis P. Amino acid losses during hemodialysis: Effects of high-solute flux and parenteral nutrition in acute renal failure. JPEN 1995; 19: 15-21.
84. Frankenfeld D, Badellino M, Reynolds N, Wiles C, Siegel J, Goodzari S. Amino acid losses and plasma concentration during continuous hemofiltration. JPEN 1993; 17: 551-561.
85. Tan CC, Lee HS, Ti TY, Lee EJC. Pharmacokinetics of intravenous vancomycin in patients with end-stage renal disease. Ther Drug Monitor 1990; 12: 29-34.
86. Rodvold K, Blum R, Fischer J. Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother 1988; 32: 848-852.
87. Bastani B, Spyker D, Minocha A, Cummings R, Westervelt F. In vivo comparison of three different hemodialysis membranes for vancomycin clearance: cuprophan, cellulose acetate, and polyacrylonitrile. Dial Transplant 1988; 17: 527-528.
88. Lanese D, Alfrey A, Molitoris B. Markedly increased clearance of vancomycin during hemodialysis using polysulfone membranes. Kidney Int 1989; 35: 1409-1412.
89. Quale J, O’Halloran J, DeVincenzo N, Barth R. Removal of vancomycin by high-flux hemodialysis membranes. Antimicrob Agents Chemother 1992; 36: 1424-1426.
90. Bohler J, Reetze-Bonorden R, Keller E, Kramer A, Schollmeyer P. Rebound of plasma vancomycin levels after hemodialysis with highly permeable membranes. Eur J Clin Pharmacol 1992; 42: 635-640.
91. DeSoi C, Sahm D, Umans J. Vancomycin elimination during high-flux hemodialysis: Kinetic model and comparison of four membranes. Am J Kidney Dis 1992; 20: 354-360.
92. Pollard T, Lamposona V, Akkerman S. Vancomycin redistribution: dosing recommendations following highflux hemodialysis. Kidney Int 1994; 45: 232-237.
93. Golper T, Marx M. Drug dosing adjustments during continuous renal replacement therapy. Kidney Int 1998; 53(suppl 66): S165-S168.
94. 2-Microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30: 385-390.
95. Kaplan AA, Halley S, Lapkin R, Graeber C. Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995; 47: 573-578.
96. Canaud B, Bosc JY, Leblanc M, Vaussenat F, Leray-Moragues H, Garred LJ, Mathieu-Daude JC, Mion C. On-line dialysis quantification in acutely ill patients: preliminary clinical experience with a multipurpose urea sensor monitoring device. ASAIO J 1998; 44: 184-190.